Ratings by Scotiabank (George Farmer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2025 | Sage Therapeutics | SAGE | Downgrade | Sector Perform (Sector Outperform) |
9.20 (9.11) |
-0.98% | Details | |
| 7/1/2025 | INmune Bio Inc. | INMB | Downgrade | Sector Underperform (Sector Outperform) |
5.33 (2.42) |
-54.6% | Details | |
| 6/13/2025 | UroGen Pharma | URGN | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Janux Therapeutics | JANX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/9/2025 | Arcellx Inc. | ACLX | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 5/6/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/10/2025 | Tempest Therapeutics | TPST | Downgrade | Sector Perform (Sector Outperform) |
7.15 (6.30) |
-11.89% | Details | |
| 3/28/2025 | Tempest Therapeutics | TPST | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 3/21/2025 | Adaptimmune Therapeutics plc | ADAP | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 3/4/2025 | INmune Bio Inc. | INMB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Janux Therapeutics | JANX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 2/20/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/13/2025 | Biogen | BIIB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 2/12/2025 | Viking Therapeutic | VKTX | New Coverage | Sector Outperform (N/A) |
29.96 (32.01) |
6.84% | Details | |
| 2/11/2025 | INmune Bio Inc. | INMB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 1/8/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/8/2025 | Kura Oncology | KURA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/11/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 12/4/2024 | Janux Therapeutics | JANX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/13/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/5/2024 | argenx SE | ARGX | Upgrade | Sector Outperform (Sector Perform) |
588.67 (564.59) |
-4.09% | Details | |
| 10/30/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 10/18/2024 | Aura Biosciences | AURA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 10/14/2024 | Tempest Therapeutics | TPST | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 10/9/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 9/30/2024 | Legend Biotech Corp. | LEGN | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 9/30/2024 | Skye Bioscience | SKYE | New Coverage | Sector Outperform (N/A) |
3.75 (3.89) |
3.73% | Details | |
| 9/27/2024 | Biomea Fusion Inc. | BMEA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 9/18/2024 | INmune Bio Inc. | INMB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 9/17/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/5/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/22/2024 | INmune Bio Inc. | INMB | New Coverage | Sector Outperform (N/A) |
6.69 (2.42) |
-63.83% | Details | |
| 8/16/2024 | Tempest Therapeutics | TPST | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Janux Therapeutics | JANX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/2/2024 | Biogen | BIIB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 7/26/2024 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/25/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 7/18/2024 | Legend Biotech Corp. | LEGN | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 7/17/2024 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/24/2024 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/13/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 6/12/2024 | Biogen | BIIB | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 6/7/2024 | Biomea Fusion Inc. | BMEA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 5/30/2024 | Janux Therapeutics | JANX | New Coverage | Sector Perform (N/A) |
47.60 (26.40) |
-44.54% | Details | |
| 5/30/2024 | Adaptimmune Therapeutics plc | ADAP | New Coverage | Sector Outperform (N/A) |
1.01 (0.28) |
-72.28% | Details | |
| 4/25/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/18/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 4/17/2024 | Legend Biotech Corp. | LEGN | Upgrade | Sector Outperform (Sector Perform) |
50.12 (41.59) |
-17.02% | Details | |
| 3/26/2024 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/14/2024 | Tempest Therapeutics | TPST | New Coverage | Sector Outperform (N/A) |
3.38 (6.30) |
86.39% | Details | |
| 3/14/2024 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Sector Outperform (N/A) |
23.43 (22.20) |
-5.25% | Details | |
| 3/14/2024 | Absci Corp. | ABSI | New Coverage | Sector Outperform (N/A) |
4.94 (3.12) |
-36.84% | Details | |
| 3/1/2024 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/29/2024 | Arcellx Inc. | ACLX | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 1/31/2024 | Kura Oncology | KURA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/31/2024 | Syndax Pharmaceuticals | SNDX | Downgrade | Sector Perform (Sector Outperform) |
20.32 (9.46) |
-53.44% | Details | |
| 1/19/2024 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 12/21/2023 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/19/2023 | Legend Biotech Corp. | LEGN | New Coverage | Sector Perform (N/A) |
61.29 (41.59) |
-32.14% | Details | |
| 12/19/2023 | Arcellx Inc. | ACLX | New Coverage | Sector Outperform (N/A) |
51.12 (67.59) |
32.22% | Details | |
| 11/29/2023 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/8/2023 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 11/7/2023 | Aura Biosciences | AURA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/1/2023 | argenx SE | ARGX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/9/2023 | Mirati Therapeutics | MRTX | Upgrade | Sector Perform (Sector Underperform) |
60.20 (58.70) |
-2.49% | Details | |
| 10/3/2023 | Syndax Pharmaceuticals | SNDX | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 9/1/2023 | Sage Therapeutics | SAGE | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 7/31/2023 | argenx SE | ARGX | New Coverage | Sector Perform (N/A) |
515.00 (564.59) |
9.63% | Details | |
| 7/27/2023 | Syndax Pharmaceuticals | SNDX | New Coverage | Sector Outperform (N/A) |
21.63 (9.46) |
-56.26% | Details | |
| 7/27/2023 | Kura Oncology | KURA | New Coverage | Sector Perform (N/A) |
9.92 (6.36) |
-35.89% | Details | |
| 7/27/2023 | Biomea Fusion Inc. | BMEA | New Coverage | Sector Outperform (N/A) |
19.31 (1.85) |
-90.42% | Details | |
| 7/27/2023 | Mirati Therapeutics | MRTX | New Coverage | Sector Underperform (N/A) |
29.98 (58.70) |
95.8% | Details | |
| 7/27/2023 | Sage Therapeutics | SAGE | New Coverage | Sector Outperform (N/A) |
36.21 (9.11) |
-74.84% | Details | |
| 7/27/2023 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Sector Perform (N/A) |
87.27 (57.29) |
-34.35% | Details | |
| 7/27/2023 | Aura Biosciences | AURA | New Coverage | Sector Outperform (N/A) |
11.35 (6.71) |
-40.88% | Details |
